Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Ear Infection Treatment Market

Companion Animal Ear Infection Treatment Market Trends

Report ID: GMI8373
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Companion Animal Ear Infection Treatment Market Trends

Growing pet ownership globally coupled with rising expenditure on animal healthcare is anticipated to drive the market growth. For instance, as per the American Pet Products Association, there is a significant rise in pet ownership in the U.S., with more than 66% of homes owning pets in 2023.
Also, growing adoption of pet insurance further aids in the market growth. For instance, the North American Pet Health Insurance Association's 2023 State of the Industry Report indicates a 124.9% increase in insured pets since 2018, totaling to more than 4.8 million insured pets by 2022.
Thus, the rising trend of pet ownership in combination with favorable pet care insurance policies alleviating the financial burden on pet owners is anticipated to facilitate market expansion.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global companion animal ear infection treatment market was valued at USD 648 million in 2023 and is expected to reach USD 1.2 billion by 2032, driven by rising pet adoption rate and increasing awareness regarding pet health.

Dogs segment held the largest market share of 61.7% in 2023, as dogs are more prone to ear infections compared to other companion animals due to their anatomy and lifestyle factors.

In 2023, North America companion animal ear infection treatment industry held a revenue share of 37.2% and will present lucrative growth avenue through 2032, attributed to a large population of companion animals with higher prevalence of ear infections, alongside the presence of well-established veterinary healthcare infrastructure.

Bayer AG, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck & Co., Inc., Nextmune, Penn Veterinary Supply, Inc., Piedmont Animal Health, Inc., Vedco, Inc., Vetnique Labs., Vetoquinol S.A., Virbac S.A., Wedgewood Village Pharmacy, LLC, and Zoetis Inc.